Case Study - AB Biotek works with Magnitude Biosciences to accelerate probiotic development

We help our partners in the nutraceuticals & ingredients industry uncover and validate the diverse health benefits of their compounds. These include novel nutraceuticals, branded ingredients and microbiotics that act through the gut microbiome (prebiotics, probiotics and postbiotics - SCFAs). Our world-leading CRO expertise enables you to elucidate the health benefits and mechanism of actions of your nutritional product fast, using an ethical alternative to testing in sentient mammals.

Download the full case study here and learn how AB Biotek and Magnitude Biosciences collaborate to develop a new generation of probiotics.


AB Biotek Human Nutrition & Health (ABB HNH), a business division of ABF Ingredients (ABFI), were working to identify key probiotics and postbiotics that improve human health. They needed to test formulations using high-throughput and ethical means, that aligned with their values, to predict and uncover potential outcomes in the gut microbiome. This was critical to inform R&D decisions and streamline their pipeline. 


We helped design and implement novel techniques to measure the effects of combinations of yeast, bacteria and prebiotics on diverse in vivo health parameters

  • Our experts developed bespoke assays and study designs to answer their specific research questions (fat deposition assay)
  • AB Biotek HNH were able to gain an in depth-look at a full range of whole organism health effects of specific compounds
  • We saved AB Biotek time by providing rich in vivo data in the format required to all internal stakeholders 
  • We helped AB Biotek gain IP for their compounds for further prioritisation and investment

‘We have formed an incredible partnership, which not only has provided AB Biotek with novel information on our formulations, but also Magnitude Biosciences with new technology to implement in their future services. All of this will be reflected in the publications of several papers and the filing of several patents. We hope to maintain this collaboration in future projects and keep developing new formulations to help human health.’

Gerald Dard, Managing Director, AB Biotek HNH

Why C. elegans?

C. elegans is a proven whole organism model for human nutrition studies. As invertebrates, C. elegans offer a sustainable option for testing, (taking care of rodents consumes much more energy, water and resources).

Furthermore, our model offers key advantages over the use of individual cell lines that lack the complexity of a whole organism, and cannot predict the biological effects on complete physiological systems. C. elegans is an established model for ageing studies, that cannot be replicated in vitro. In addition, C.elegans has intrinsic properties making it an ideal model for testing natural products, especially microbiotics.

Ethical in vivo model to discover health benefits and patent early

✓ Sustainable, ethical alternative to testing in sentient mammals

✓ Unique technology and expertise to discover in vivo bioactive potential for IP

✓  Whole model organism data to predict safety and  biological effects

✓ Intrinsic advantages for microbiotic testing (prebiotics, probiotics, and postbiotics / SCFAs)

✓ Transgenic models and specialised assays for nutraceutical & ingredients 

Read more on our Why C.elegans? page to discover the full range of C. elegans advantages. 

Unique technology and expertise

Our unique automated WormGazerTM technology provides in vivo data on integrated health measures for relevant and consistent results to characterise your product and its benefits, so you can patent early.

Our technology and expert interdisciplinary team, with over 80+ years joint C. elegans experience, means collaborate with you to bring the most relevant assays for nutritional applications, including a range of transgenic models.

Read more about our novel, patented biophotonics platform. 

Products we test

  • Health Supplements
  • Ingredients
  • Botanicals
  • Cosmeceuticals
  • Drug Compounds
  • Microbial Formulations
  • Probiotics
  • Prebiotics
  • Microbial Extracts
  • Live Microbes
  • Bio-Agricultural Compounds
  • Manufacturing Materials
  • Chemicals

Related Resources

The Nematode Corner: Delaying Forgetting - How Ice and Lithium Affect Memory in C. elegans
Delaying Forgetting - How Ice and Lithium Affect Memory in C. elegans...Read More
The Nematode Corner: Toxicity Testing with C. elegans
Welcome back to "The Nematode Corner" where we explore the fascinating world of Caenorhabditis elega...Read More
Brochure: Health & Nutrition
Brochure: Health & Nutrition - read and download the brochure...Read More
Probiota 2024: Exploring Probiotic Efficacy Beyond CFUs
A couple of weeks ago we attended Probiota 2024 in Milan, a global meeting to discuss the science an...Read More
Case Study: Identifying a lead candidate for slowing ageing with Gerostate Alpha
GeroState Alpha is a pharmaceutical company, based at the Buck Institute for Research on Ageing in N...Read More
Case Study: Measuring efficacy to slow ageing for drug discovery biotech Five Alarm Bio
Five Alarm Bio, a UK drug discovery startup focussing on the underlying mechanisms of ageing to deve...Read More
The Nematode Corner: Unearthing Nutraceutical Discoveries
Welcome back to "The Nematode Corner," where we continue our journey into the extraordinary world of...Read More
The Nematode Corner: Powering Industry Progress
Welcome to the fascinating world of C. elegans, a microscopic nematode worm that holds the key to un...Read More
Case Study - AB Biotek works with Magnitude Biosciences to accelerate probiotic development
We help our partners in the nutraceuticals & ingredients industry uncover and validate the diver...Read More
Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease
Lundbeck collaborates with Magnitude on innovate platform to test neurodegenerative disease interven...Read More
Tiny Worms- Experiments Fast
David Weinkove, CEO of Magnitude Biosciences joins New Matter ...Read More
Case Study: Michelin & Magnitude Biosciences
Michelin, a Fortune 500 consumer good manufacturing company and the global leader in tyre manufactur...Read More
ELRIG Drug Discovery 2021
Take a look at our Poster from ELRIG Drug Discovery 2021: Automated Monitoring of C. elegans&nb...Read More
Frontiers in Aging: Applying C. elegans to industrial drug discovery
Just published in Frontiers in Aging: Applying C. elegans to industrial drug discovery...Read More
C. elegans to accelerate industrial drug discovery and address the costs and challenges of early preclinical research
Magnitude Bioscience CEO, David Weinkove, discusses the application of C. elegans to accelerate the ...Read More
Developing a System to Quantify Efficacy of Neurodegeneration Therapeutics Using Automated Monitoring of C. elegans
Check out our poster showing how we can quantify the efficacy of neurodegeneration models...Read More
C. elegans mobility decline
This video shows an automated method to quantify that decline developed by Magnitude Biosciences whi...Read More
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control satiety
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control sati...Read More
Chemosensory Neurons Modulate the Response to Oomycete Recognition in Caenorhabditis elegans
The Barkoulas Lab, including our own Michael Fasseas , find an Oomycetes recognition response in&nbs...Read More
UK SPINE Recording
Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the...Read More
Microbiome SIG Webinar Series
Our CEO, Dr. David Weinkove, explains how healthspan readouts can be used to understand mechanisms i...Read More
Automated Imaging of C. elegans for Ageing, Neurodegeneration and Behaviour
How large scale non-invasive imaging of C. elegans to enable reliable measurement of Agein...Read More
C. elegans Automated Imaging Platform
Magnitude Biosciences presentation from ELRIG online 2020 on the use of C. elegans in pre-...Read More
C. elegans Automated Imaging in Drug Discovery
De-risking drug candidates ahead of rodent studies with a non-mammalian model for ageing, neurodegen...Read More
An overview of the use of C. elegans in longevity research including the genetic manipulation of animals.
An overview of the use of C. elegans in longevity research including the genetic manipulat...Read More

Get regular updates in your inbox

Sign up to our newsletter today, to get access to the latest company and industry news